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Abstract
Background: Ischemic stroke is a life-threatening condition due to obstructed blood supply of the brain. Elevation
of plasma C-reactive protein, an important inflammatory marker, was known to associate with increased risk of
ischemic stroke. Previous studies reported association between genetic variants of HNF1A and plasma level of C-
reactive protein. The HNF1A gene encodes a hepatocyte transcription factor which might have regulatory effects
on C-reactive protein synthesis in liver. Therefore, the C-reactive protein associated gene HNF1A seems to be a
promising candidate gene for ischemic stroke.
Results: We used HNF1A as a candidate gene of ischemic stroke and evaluated seven common variants of HNF1A
for their contribution to ischemic stroke. The association analysis of HNF1A variants with ischemic stroke was
performed in a Chinese population with 918 cases and 979 controls. For total ischemic stroke and large vessel
disease subtype, none of variants exceeded significant threshold. For small vessel disease subtype of ischemic
stroke, the G allele of rs7953249 showed nominal association (OR = 0.82, p = 0.04) after data adjustment for
conventional risk factors. However, our preliminary results did not survived bonferroni correction for multiple
comparisons.
Conclusions: Common genetic variants of HNF1A showed nominal association with small vessel disease subtype
of ischemic stroke though not survived bonferroni correction for multiple comparisons. The association between
HNF1A and ischemic stroke is limited by small effects of individual SNPs. Our study provided additional genetic
evidences to understand the role of HNF1A gene and C-reactive protein underlying ischemic stroke.
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Background
Stroke accounts for the second most common cause of
death in the world [1]. There were 2.5 million patients
newly identified as stroke cases and 1.6 million patients
died of stroke every year in China [2]. There were two
clinical subtypes of stroke namely ischemic stroke and
hemorrhagic stroke. In China, more than 60 % stroke
patients were ischemic characterized by obstructed
blood supply of the brain [3, 4]. Given the huge financial
burden imposed by healthcare expenses of stroke,
there have been intensive efforts to develop effective
intervention and prevention strategies against this life-
threatening disease [5, 6]. Previous epidemiological studies
of ischemic stroke proposed several risk factors including
hypertension, cigarette smoking, diabetes and obesity [7].
In addition to previously proposed conventional risk
factors, genetic factors were also suggested to play a role
underlying ischemic stroke [8].
Some ischemic stroke cases could be attributed to
mendelian disorders which are caused by mutation of a
single gene [9]. Whereas, genetic etiologies underlying
most ischemic stroke cases were believed to be polygenic
[10]. The candidate gene approach has been widely
applied to identify susceptibility genes of ischemic stroke
upon previous biological and functional understanding
of the disease. Atherosclerosis has been known as a
common cause of ischemic stroke [11]. It was reported
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that inflammation might associate with plaque instability
and finally result in atherosclerosis [12, 13]. Meanwhile,
observational studies also found that elevation of plasma
C-reactive protein (CRP), an important inflammatory
marker, was associated with increased risk of ischemic
stroke [14, 15]. Therefore, genes affecting CRP level
seem to be promising candidate genes of ischemic
stroke.
Circulating level of CRP is directly associated with the
CRP gene. Indeed, genetic variants of CRP gene were
identified for their contribution to both CRP level and
susceptibility of ischemic stroke [16]. However, CRP
gene itself could only explain a small portion of CRP
variance. In addition to CRP gene, genome-wide associ-
ation studies (GWAS) identified a number of genetic
variants associated with circulating level of CRP. As
such, the HNF1A gene encoding Hepatocyte Nuclear
Factor 1 Homeobox A were found to associate with CRP
[17, 18]. HNF1A is mainly expressed in liver and acts as
a transcription factor. As CRP is mainly synthesized in
liver by hepatocytes [19], the HNF1A gene might be an
important regulator of CRP and associate with ischemic
stroke through its regulatory effects on CRP.
In the present study, we selected HNF1A as a candi-
date gene of ischemic stroke and focused on several
single nucleotide polymorphisms (SNPs) of HNF1A that
were known to be associated with circulating CRP levels.
We performed SNP genotyping and association analysis
in a large unrelated Chinese population. The association
between HNF1A and ischemic stroke and its subtypes
provided further evidence to understand genetic etiolo-
gies underlying ischemic stroke.
Methods
Subjects
In total, 918 ischemic stroke cases and 979 healthy con-
trols were recruited from the Second People’s Hospital
Affiliated to Fujian University of Traditional Chinese
Medicine, Fujian Provincial Hospital, Fuzhou General
Hospital of Nanjing Military Command and Fujian
University of Traditional Chinese Medicine Subsidiary
Rehabilitation Hospital. Their demographic information
was indicated in Table 1. This study was approved by
the institutional review board of each participating hos-
pitals. Written consents and peripheral blood samples
were obtained from each participant. All participants are
genetically unrelated Han Chinese. The stroke status of
each ischemic stroke cases was determined by Magnetic
Resonance Imaging and their clinical records as con-
firmed by two clinicians. The large-vessel disease (LVD)
and small-vessel disease (SVD) subtype of each ischemic
stroke case was determined by the TOAST stroke sub-
type classification system [20]. Healthy controls without
history of ischemic stroke and neurological impairments
were recruited from healthcare center of aforementioned
hospitals. The demographic information of all partici-
pants was listed in Table 1.
SNP selection and genotyping
Eight SNPs of HNF1A namely rs7310409, rs735396,
rs1169300, rs2464196, rs7953249, rs2650000, rs1169302
and rs1169307 previously associated with plasma CRP
were selected for our study [18]. Due to failure of primer
design,rs735396 was replaced by another SNP in linkage
disequilibrium namely rs1169306. In addition, rs1169300
was excluded as it was in linkage disequilibrium with
rs2464196. Finally, there were seven SNPs of HNF1A
namely rs1169302, rs1169306, rs1169307, rs2464196,
rs2650000, rs7310409 and rs7953249 selected for subse-
quent genotyping and association analysis.
Genotyping were performed at CapitalBio Corporation
(Beijing, China) with Sequenom MassARRAY platform
(San Diego, U.S) according to the manufacturer’s protocol.
Briefly, genomic DNA was extracted from whole blood of
each individual using Wizard® Genomic DNA Purification
Kit (Promega, Madison, WI, USA). DNA concentration
was determined by NanoDrop 1000 (Waltham, U.S).
Multiplex reaction primers were designed using the
MassARRAY Assay Design software package (v3.1). Mass
determination was carried out with the MALDI-TOF
mass spectrometer and Mass ARRAY Type 4.0 software
was used for data acquisition.
Statistical analysis
Each SNP was tested for Hardy-Weinberg equilibrium
(HWE). Associations between HNF1A and ischemic
stroke and its subtypes were analyzed under different
models (additive, dominant, recessive and genotype)
Table 1 Demographic information of participants
Group Cases (n = 918) Controls (n = 979)
Large Vessel Disease, n (%) 465 (51 %) /
Small Vessel Disease, n (%) 453 (49 %)
Age, years 69.39 ± 10.45* 67.04 ± 10.26
Male, n (%) 601 (65 %)* 562 (57 %)
Female, n (%) 317 (35 %)* 417 (43 %)
Hypertension, n (%) 216 (24 %)* 316 (32 %)
Diabetes, n (%) 598 (65 %)* 126 (13 %)
Smoking, n (%) 626 (68 %)* 170 (17 %)
Drinking, n (%) 736 (80 %)* 81 (8 %)
Triglyceride, mmol/L 1.59 ± 0.94 1.60 ± 0.91
Total Cholesterol, mmol/L 4.62 ± 1.21* 5.22 ± 1.08
Low Density Lipoprotein, mmol/L 3.04 ± 1.66* 3.42 ± 1.00
High Density Lipoprotein, mmol/L 1.20 ± 0.52* 1.35 ± 0.34
Data were shown as mean ± standard deviation (SD) or as n (%). Significant
differences between cases and controls were indicated with an asterisk (*)
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through PLINK software [21]. The odds ratio (OR) and its
corresponding 95 % confidence interval (L96 and U95)
were used to indicate the effect size of each variants.
The association results were adjusted for known risk
factors of ischemic stroke including age, sex, hyper-
tension, diabetes, smoking, drinking, triglyceride, total
cholesterol, low density lipoprotein and high density
lipoprotein.
Results
In this study, we genotyped seven common SNPs of
HNF1A in a large unrelated Chinese population and
performed case–control based association analysis with is-
chemic stroke and its subtypes. The genotype distribution
of each SNP in case and control groups was analyzed
under additive, dominant, recessive and genotype models
for its association with ischemic stroke and its subtypes.
Our results were adjusted for known risk factors of
ischemic stroke including age, sex, hypertension, diabetes,
smoking, drinking, triglyceride, total cholesterol, low
density lipoprotein and high density lipoprotein.
The association between seven SNPs of HNF1A and
overall ischemic stroke were indicated in Table 2. Before
data adjustment, none of these SNPs showed significant
association with overall ischemic stroke (minimum p =
0.09). After data adjustment for known risk factors, none
of above results became significant (minimum p = 0.16).
The association between seven SNPs of HNF1A and
large vessel disease subtype of ischemic stroke were indi-
cated in Table 3. Before data adjustment, none of these
SNPs showed significant association with large vessel
disease subtype of ischemic stroke (minimum p = 0.25).
After data adjustment for known risk factors, the T allele
of rs1169302 showed marginal association under domin-
ant model (TT + TG v.s GG, OR = 0.88, p = 0.05). In
addition, its heterozygote genotype TG also showed mar-
ginal association (OR = 0.87, p = 0.05). After bonferroni
correction for multiple comparisons, none of these seven
SNPs exceeded significant threshold.
The association between seven SNPs of HNF1A and
small vessel disease subtype of ischemic stroke were
indicated in Table 4. Before data adjustment, the A allele
of rs2650000 showed significant association with small
vessel disease subtype of ischemic stroke under additive
model (OR = 0.83, p = 0.03) and dominant model (AA +
AC v.s CC, OR = 0.74, p = 0.02). Its homozygote geno-
type AA also showed significant association (OR = 0.70,
p = 0.03). In addition, the G allele of rs7953249 showed
significant association with small vessel disease subtype
of ischemic stroke under additive (OR = 0.84, p = 0.03)
and dominant models (GG + GA v.s AA, OR = 0.75,
p = 0.02). Its homozygote genotype AA also showed
significant association (OR = 0.70, p = 0.03). After data
adjustment for known risk factors, only the G allele of
rs7953249 remained significant under additive model
(OR = 0.82, p = 0.04) and its homozygote genotype GG
(OR = 0.66, p = 0.04) respectively. After bonferroni
correction for multiple comparisons, none of these
seven SNPs exceeded significant threshold.
Discussion
Although atherosclerosis was known to be a common
cause of ischemic stroke, molecular pathogenesis under-
lying atherosclerosis and ischemic stroke remain complex
and elusive. Inflammation is a series of physiological
responses to stimulations of various pathogens. It occurs
systemically and associates with a number of human
diseases. CRP is a well-known inflammatory marker that
could be quantitated in circulating blood. Elevation of cir-
culating CRP has been recognized as a predictive marker
for atherosclerosis and cardiovascular diseases. In recent
years, studies in general populations observed association
of CRP with ischemic stroke [15, 22, 23]. Whereas, contra-
dictory results were also reported by studies in different
cohorts [24, 25]. Identification of CRP-associated genetic
variants provided an alternative aspect to elucidate contri-
bution of CRP to ischemic stroke. Genetics variants of
CRP gene which were directly associated with circulating
CRP level showed significant association with ischemic
stroke in a Chinese population [16]. In addition to CRP
gene, circulating CRP level was associated with some
regulatory genes that could also be considered as candi-
date genes of ischemic stroke. CRP is mainly synthesized
in liver [19]. The hepatocyte nuclear factor HNF1A is a
transcription factor that was believed to have regulatory
effects on CRP. Indeed, association between common
SNPs of HNF1A and circulating CRP level were reported
in large-scale GWAS [17, 18].
In our study, we used these variants of HNF1A as can-
didate variants of ischemic stroke and performed associ-
ation analysis in a Chinese cohort. For overall ischemic
stroke and its LVD subtype, none of SNPs exceeded sig-
nificant threshold. For SVD subtype of ischemic stroke,
the A allele of rs2650000 and the G allele of rs7953249
showed nominal association with the disease. Given the
broad effects of inflammation, interplay between CRP
and conventional risk factors of ischemic stroke would
cause confounding biases which might explain the
inconclusive and controversial role of CRP underlying is-
chemic stroke in previous studies. To reduce confound-
ing biases, we adjusted both non-modifiable risk factors
(age and sex) and conventional risk factors (hyperten-
sion, diabetes, and etc.) during association analysis
between HNF1A and ischemic stroke. After data adjust-
ment, only the G allele of rs7953249 remained signifi-
cant with protective effect on SVD subtype of ischemic
stroke. Thus, our preliminary results further supported
the independent contribution of HNF1A and CRP to
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ischemic stroke. In addition, we applied bonferroni
correction which was known to be one of the most
stringent methods for multiple comparisons to the
seven SNPs of HNF1A. The significant threshold after
bonferroni correction became approximate 0.007
(0.05/7) therefore none of analyzed variants persisted
significant.
For polygenic diseases such as ischemic stroke, there
were considerable portion of unexplained heritability
remained as missing heritability [26]. Although some
Table 2 Association analysis of HNF1A with overall ischemic stroke
SNP Allele Model Unadjusted Adjusted
OR L95 U95 p-value OR L95 U95 p-value
rs1169302 T Additive 0.97 0.84 1.12 0.67 0.93 0.78 1.10 0.37
Dominant 0.94 0.79 1.13 0.54 0.88 0.71 1.10 0.27
Recessive 1.02 0.74 1.40 0.91 0.98 0.67 1.44 0.93
Genotype TT 0.99 0.71 1.37 0.94 0.93 0.62 1.37 0.70
Genotype TG 0.94 0.77 1.13 0.49 0.88 0.70 1.10 0.26
rs1169306 C Additive 1.03 0.91 1.17 0.65 1.00 0.85 1.17 0.99
Dominant 0.98 0.79 1.21 0.86 0.95 0.73 1.22 0.67
Recessive 1.10 0.89 1.37 0.36 1.14 0.88 1.47 0.32
Genotype CC 1.06 0.82 1.38 0.65 1.00 0.73 1.37 0.99
Genotype CT 0.94 0.75 1.18 0.62 0.83 0.63 1.08 0.16
rs1169307 T Additive 0.95 0.79 1.15 0.61 0.95 0.75 1.20 0.69
Dominant 0.94 0.76 1.17 0.59 0.95 0.73 1.22 0.67
Recessive 0.98 0.47 2.04 0.96 0.98 0.39 2.48 0.97
Genotype TT 0.97 0.46 2.02 0.93 0.97 0.38 2.45 0.94
Genotype TC 0.94 0.76 1.17 0.59 0.94 0.73 1.23 0.67
rs2464196 G Additive 1.04 0.91 1.18 0.58 1.01 0.86 1.18 0.89
Dominant 0.99 0.80 1.22 0.90 0.89 0.69 1.15 0.37
Recessive 1.12 0.90 1.39 0.30 1.16 0.90 1.50 0.26
Genotype GG 1.08 0.83 1.40 0.58 1.03 0.75 1.40 0.87
Genotype GA 0.94 0.76 1.18 0.62 0.83 0.64 1.09 0.18
rs2650000 A Additive 0.90 0.79 1.02 0.09 0.91 0.78 1.07 0.26
Dominant 0.84 0.68 1.03 0.09 0.86 0.67 1.11 0.24
Recessive 0.89 0.72 1.10 0.28 0.91 0.71 1.18 0.49
Genotype AA 0.80 0.61 1.04 0.09 0.83 0.61 1.14 0.26
Genotype AC 0.85 0.68 1.07 0.16 0.87 0.67 1.14 0.32
rs7310409 A Additive 0.97 0.85 1.11 0.69 1.01 0.86 1.18 0.94
Dominant 0.97 0.80 1.17 0.75 1.00 0.79 1.26 0.98
Recessive 0.96 0.75 1.23 0.74 1.03 0.76 1.37 0.87
Genotype AA 0.95 0.72 1.24 0.69 1.02 0.73 1.42 0.91
Genotype AG 0.98 0.80 1.20 0.82 0.99 0.77 1.27 0.93
rs7953249 G Additive 0.90 0.79 1.03 0.12 0.91 0.77 1.06 0.22
Dominant 0.84 0.68 1.03 0.10 0.85 0.66 1.09 0.21
Recessive 0.90 0.72 1.13 0.36 0.91 0.70 1.19 0.48
Genotype GG 0.81 0.62 1.06 0.12 0.82 0.60 1.13 0.23
Genotype GA 0.85 0.69 1.06 0.16 0.86 0.66 1.12 0.27
All SNPs were analyzed under allele, genotype, dominant and recessive models. Statistical analysis was performed using Chi-square test. P-value less than 0.05
were indicated in bold. Effect size was indicated in odds ratio (OR) with 95 % confidence interval (L95 and U95). After bonferroni correction, none of the associations
highlighted in bold remained significant
Shi et al. BMC Medical Genetics  (2016) 17:51 Page 4 of 8
genetic variants were identified by candidate gene based
approach, they were usually believed to be common vari-
ant with small effect [27]. In the present study, effects of
each SNPs of HNF1A on ischemic stroke were limited
which might explain that none of SNPs exceed the
significant threshold yielded by bonferroni correction.
As such, expanding sample size could be an option to
confirm the association between HNF1A and ischemic
stroke. Alternatively, functional characterization of
HNF1A variants would be a more direct way to explain
Table 3 Association analysis of HNF1A with large vessel disease
SNP Allele Model Unadjusted Adjusted
OR L95 U95 p-value OR L95 U95 p-value
rs1169302 T Additive 0.92 0.77 1.10 0.35 0.84 0.68 1.04 0.11
Dominant 0.88 0.70 1.10 0.26 0.76 0.58 1.00 0.05
Recessive 0.98 0.66 1.45 0.91 0.94 0.58 1.50 0.78
Genotype TT 0.92 0.61 1.38 0.69 0.82 0.50 1.34 0.44
Genotype TG 0.87 0.69 1.10 0.25 0.75 0.56 1.00 0.05
rs1169306 C Additive 1.01 0.87 1.19 0.86 0.96 0.79 1.17 0.72
Dominant 1.00 0.77 1.29 0.98 0.84 0.61 1.14 0.26
Recessive 1.04 0.80 1.36 0.75 1.09 0.80 1.50 0.58
Genotype CC 1.03 0.75 1.42 0.86 0.94 0.64 1.38 0.74
Genotype CT 0.98 0.75 1.29 0.89 0.79 0.57 1.10 0.17
rs1169307 T Additive 0.95 0.75 1.20 0.67 0.98 0.73 1.30 0.87
Dominant 0.92 0.71 1.19 0.52 0.96 0.70 1.31 0.78
Recessive 1.26 0.55 2.90 0.59 1.18 0.41 3.44 0.76
Genotype TT 1.23 0.53 2.83 0.63 1.17 0.40 3.40 0.78
Genotype TC 0.90 0.68 1.18 0.43 0.94 0.68 1.31 0.72
rs2464196 G Additive 1.03 0.87 1.20 0.76 0.98 0.81 1.19 0.85
Dominant 1.01 0.77 1.30 0.97 0.85 0.62 1.17 0.32
Recessive 1.07 0.82 1.39 0.64 1.12 0.82 1.54 0.48
Genotype GG 1.05 0.76 1.45 0.75 0.97 0.66 1.43 0.87
Genotype GA 0.98 0.75 1.30 0.91 0.80 0.58 1.12 0.20
rs2650000 A Additive 1.04 0.89 1.22 0.60 1.00 0.82 1.22 0.99
Dominant 1.06 0.81 1.38 0.67 0.97 0.71 1.34 0.87
Recessive 1.06 0.82 1.38 0.66 1.03 0.75 1.42 0.85
Genotype AA 1.09 0.79 1.51 0.59 1.00 0.68 1.48 0.98
Genotype AC 1.04 0.79 1.38 0.76 0.96 0.69 1.34 0.82
rs7310409 A Additive 1.07 0.91 1.26 0.40 1.15 0.95 1.41 0.15
Dominant 1.09 0.85 1.38 0.50 1.14 0.85 1.53 0.38
Recessive 1.11 0.83 1.49 0.47 1.31 0.92 1.86 0.13
Genotype AA 1.16 0.83 1.61 0.39 1.36 0.91 2.03 0.13
Genotype AG 1.06 0.82 1.37 0.64 1.07 0.79 1.46 0.67
rs7953249 G Additive 0.97 0.83 1.14 0.71 1.00 0.82 1.22 0.98
Dominant 0.94 0.73 1.22 0.66 0.96 0.70 1.32 0.81
Recessive 0.98 0.75 1.28 0.86 1.05 0.76 1.45 0.78
Genotype GG 0.94 0.68 1.30 0.71 1.01 0.68 1.49 0.97
Genotype GA 0.95 0.72 1.24 0.69 0.94 0.68 1.31 0.73
All SNPs were analyzed under allele, genotype, dominant and recessive models. Statistical analysis was performed using Chi-square test. P-value less than 0.05
were indicated in bold. Effect size was indicated in odds ratio (OR) with 95 % confidence interval (L95 and U95). After bonferroni correction, none of the associations
highlighted in bold remained significant
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its contribution to ischemic stroke. The rs7953249, lo-
cated upstream of HNF1A, was associated with plasma
N-glycan levels and the HNF1A gene was shown to be a
regulator of protein glycosylation [28]. Dysregulation of
glycosylation was known to associate with a wide range
of diseases including cancer, diabetes and cardiovascular
diseases [29]. A number of mutations of HNF1A gene
were associated with maturity-onset diabetes of the
young (MODY), an early onset form of type 2 diabetes
[30, 31]. Thus, pleiotropic effects of HNF1A variants
on CRP and N-glycan are worthwhile to be further
investigated.
Table 4 Association analysis of HNF1A with small vessel disease
SNP Allele Model Unadjusted Adjusted
OR L95 U95 p-value OR L95 U95 p-value
rs1169302 T Additive 1.02 0.86 1.21 0.81 0.99 0.81 1.22 0.95
Dominant 1.02 0.81 1.27 0.89 1.01 0.77 1.32 0.95
Recessive 1.06 0.72 1.56 0.77 0.94 0.60 1.50 0.81
Genotype TT 1.06 0.71 1.59 0.77 0.95 0.59 1.54 0.85
Genotype TG 1.01 0.79 1.28 0.96 1.02 0.77 1.36 0.89
rs1169306 C Additive 1.05 0.89 1.23 0.57 1.05 0.86 1.27 0.63
Dominant 0.97 0.74 1.25 0.80 0.96 0.70 1.32 0.81
Recessive 1.17 0.90 1.52 0.24 1.18 0.86 1.61 0.31
Genotype CC 1.10 0.80 1.51 0.57 1.10 0.75 1.61 0.63
Genotype CT 0.91 0.69 1.20 0.49 0.90 0.65 1.26 0.54
rs1169307 T Additive 0.95 0.75 1.21 0.70 0.90 0.67 1.21 0.50
Dominant 0.97 0.75 1.26 0.81 0.91 0.66 1.25 0.56
Recessive 0.70 0.25 1.94 0.49 0.69 0.19 2.50 0.58
Genotype TT 0.70 0.25 1.94 0.49 0.68 0.19 2.45 0.56
Genotype TC 0.99 0.76 1.29 0.92 0.92 0.67 1.27 0.63
rs2464196 G Additive 1.05 0.89 1.23 0.56 1.05 0.87 1.28 0.59
Dominant 0.97 0.74 1.25 0.80 0.97 0.71 1.33 0.87
Recessive 1.18 0.91 1.53 0.22 1.18 0.86 1.62 0.30
Genotype GG 1.10 0.80 1.52 0.55 1.11 0.76 1.63 0.59
Genotype GA 0.91 0.69 1.20 0.49 0.91 0.65 1.27 0.59
rs2650000 A Additive 0.83 0.71 0.98 0.03 0.84 0.69 1.02 0.07
Dominant 0.74 0.58 0.96 0.02 0.79 0.58 1.08 0.14
Recessive 0.83 0.63 1.09 0.18 0.79 0.57 1.09 0.15
Genotype AA 0.70 0.50 0.96 0.03 0.70 0.47 1.04 0.08
Genotype AC 0.77 0.58 1.00 0.05 0.84 0.61 1.16 0.29
rs7310409 A Additive 0.88 0.75 1.04 0.14 0.90 0.74 1.10 0.30
Dominant 0.87 0.68 1.10 0.23 0.94 0.70 1.24 0.65
Recessive 0.81 0.59 1.11 0.20 0.77 0.53 1.13 0.18
Genotype AA 0.76 0.54 1.08 0.13 0.77 0.50 1.17 0.22
Genotype AG 0.90 0.70 1.15 0.41 0.99 0.74 1.34 0.96
rs7953249 G Additive 0.84 0.71 0.98 0.03 0.82 0.67 0.99 0.04
Dominant 0.75 0.58 0.96 0.02 0.78 0.57 1.05 0.10
Recessive 0.83 0.62 1.10 0.18 0.75 0.53 1.05 0.09
Genotype GG 0.70 0.50 0.97 0.03 0.66 0.45 0.98 0.04
Genotype GA 0.77 0.59 1.01 0.06 0.83 0.60 1.14 0.25
All SNPs were analyzed under allele, genotype, dominant and recessive models. Statistical analysis was performed using Chi-square test. P-value less than 0.05
were indicated in bold. Effect size was indicated in odds ratio (OR) with 95 % confidence interval (L95 and U95). After bonferroni correction, none of the associations
highlighted in bold remained significant
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Conclusion
In conclusion, our study used HNF1A as a candidate
gene of ischemic stroke and genotyped seven common
SNPs of HNF1A in a Chinese population. We found
nominal association between HNF1A and small vessel
disease subtype of ischemic stroke though not survived
bonferroni correction for multiple comparisons. Cur-
rently, the contribution of seven candidate variants of
HNF1A to ischemic stroke should be interpreted with
caution. It is worthwhile to replicate the association
between HNF1A and ischemic stroke in expanded co-
horts and to characterize the functional role of HNF1A
underlying ischemic stroke.
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